Paper
Document
Submit new version
Download
Flag content
0

213P Duration of adjuvant immune checkpoint inhibitors in hepatocellular carcinoma with high-risk recurrence factors: A prospective, multicentric cohort study

Published
Dec 1, 2024
Show more
Save
TipTip
Document
Submit new version
Download
Flag content
0
TipTip
Save
Document
Submit new version
Download
Flag content

Abstract

Paper PDF

This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.